v3.26.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Common Stock Warrants

As of December 31, 2025, the Company had the following common stock warrants outstanding:

 

Issue Date  Expiration
Date
  Warrants
Outstanding
   Exercise
Price
   Offering
1/21/2016  1/14/2026   28,716   $7.56   Private placement offering – issued to placement agent
5/2/2016  5/2/2026   18,175    7.56   Private placement offering – issued to placement agent
4/28/2017  4/28/2027   32,458    8.42   Private placement offering – issued to placement agent
5/17/2017  5/17/2027   14,969    8.42   Private placement offering – issued to placement agent
4/8/2021  4/8/2031   26,042    14.40   Debt financing – issued to lender
5/30/2024  5/30/2034   84,227    14.84   Debt financing – issued to lender
5/30/2024  5/30/2034   19,649    14.84   Debt financing – issued to lender
9/9/2025  9/9/2035   25,269    14.84   Debt financing – issued to lender
9/9/2025  9/9/2035   25,268    14.84   Debt financing – issued to lender
10/18/2023  N/A   5,747,787    0.001   Private placement offering – issued to investors
7/31/2025  N/A   400,000    0.001   Equity offering – issued to underwriters
Total warrants outstanding   6,422,560         
Schedule of Common Stock Warrants Outstanding

The following table summarizes the activity for all common stock warrants outstanding:

 

   Common stock warrants   Weighted- average exercise price per share 
Outstanding as of December 31, 2024   11,268,939   $4.04 
Issued   450,537    1.67 
Exercised   (5,282,375)   8.07 
Surrendered upon cashless exercise   (14,541)   10.43 
Expired        
Outstanding as of December 31, 2025   6,422,560   $0.53